Search results for: Pricing and Reimbursement
Filter search results
Value Based Pricing in Sweden: Lessons for Design?
28 November 2012
…made extensive use of coverage with evidence development to allow reimbursement for orphan drugs and approved all but one of the 30 applications for reimbursement received between 2003 and 2010….
Differential Pricing – A Win-Win Solution?
2 March 2011
Summarised in this post is a just-released OHE Occasional Paper that examines the potentially positive impact of differential pricing in Europe and the overall negative effects of international reference pricing…
European Union Pharmaceutical Markets: A Case for Differential Pricing?
11 August 2015
…groups of buyers, with different abilities and willingness to pay, should efficiently be charged. From both a theoretical and a company’s decision-making perspective, the ability through pricing to allocate contributions…
Key Considerations for Early Access Schemes for Single-Administration (One-Time) Therapies
1 June 2021
…where the benefits are judged to be greater than the risks. Following regulatory approval, there are different national pricing and reimbursement processes, which in most cases, must conclude before patients…
Access to Orphan Drugs in the EU
21 October 2010
…determining pricing and reimbursement (P&R) also affect access. OHE’s Dr. Jorge Mestre-Ferrandiz recently presented the results of comparative research on these factors at the 9th Annual Pricing and Reimbursement Conference in…
Office of Health Economics latest research estimates 20 people a day die in unrelieved pain in the UK in the last 3 months of their lives
26 November 2024
…through pioneering and innovative research, analysis, and education. As a global thought leader and publisher in the economics of health, health care, and life sciences, we partner with Universities, Government,…
Understanding societal preferences for priority by disease severity in England & Wales
14 November 2024
…were determined, or how they may be aligned with societal preferences. We surveyed a representative sample of the population of England and Wales to understand how the public would prioritise…
Around The World in HTAs: Thailand – An Ever-Evolving Policy Tool
9 September 2024
…Thailand’s HTA agency, the Health Intervention and Technology Assessment Program (HITAP), and HTA has since become a requirement before making reimbursement decisions for the UCS. The other two schemes, CSMBS and SSS,…
Value-Based Pricing: OHE Comments
23 March 2011
…its comments and made the full text of its remarks available here. Briefly stated, key issues addressed in our response include the following. 1. Value-based pricing (VBP) can, and should,…